Abraham Ceesay - Insider Trading & Ownership

Entity
Individual
Location
C/O Scpharmaceuticals, Inc., 2400 District Avenue Suite 310, Burlington, MA
Summary
The estimated net worth of Abraham Ceesay is at least $1.38M dollars as of June 13, 2024. Abraham Ceesay is the President of Cerevel Therapeutics Holdings, Inc. and owns shares of Cerevel Therapeutics Holdings, Inc. stock worth about $1.23M. Abraham Ceesay is the Director of Pacira BioSciences, Inc. and owns shares of Pacira BioSciences, Inc. (PCRX) stock worth about $148K.
All Insider Reports
All Insider Reports

Ownership of Abraham Ceesay

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CERE Cerevel Therapeutics Holdings, Inc. President $1.23M Feb 6, 2023
PCRX Pacira BioSciences, Inc. Director $148K Jun 12, 2024
RAPP Rapport Therapeutics, Inc. Chief Executive Officer, Director Jun 6, 2024

Insider Transactions Reported by Abraham Ceesay:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.